artelac complete mdo® combination drops
lunatus drug store llc germany - 10 ml dropper bottle - drops - combination - medical devices-medical devices
artelac® complete sdu combination drops
lunatus drug store llc germany - 30's (0.5ml single dose vial x 30) - drops - combination - medical devices-medical devices
artelac advanced
sodium hyaluronate -
artelac® splash eye drops
sodium hyaluronate -
artelac complete sdu eye drop eye drops, solution
dr. gerhard mann chem. - pharma. fabrik gmbh, germany - sodium hyaluronate,triglycerides medium chain,carbomer - eye drops, solution - 2.4,2,0.625 mg/g,
artelac ectoin sdu eye drops
dr. gerhard mann chem. - pharma. fabrik gmbh, germany - ectoine - eye drops - 20 mg,
nitrile examination/treatment glove, non-powdered
martellor pty ltd -
nitrile examination/treatment glove, non-powdered
martellor pty ltd -
dr. gerhard mann artelac rebalance eye drop
bausch & lomb (singapore) private limited - ophthalmology - eye lubricant and contact lens wetting.
zenatane- isotretinoin capsule, gelatin coated
physicians total care, inc. - isotretinoin (unii: eh28up18if) (isotretinoin - unii:eh28up18if) - isotretinoin 20 mg - severe recalcitrant nodular acne zenatane is indicated for the treatment of severe recalcitrant nodular acne. nodules are inflammatory lesions with a diameter of 5 mm or greater. the nodules may become suppurative or hemorrhagic. “severe,” by definition,2 means “many” as opposed to “few or several” nodules. because of significant adverse effects associated with its use, zenatane should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. in addition, zenatane is indicated only for those female patients who are not pregnant, because zenatane can cause severe birth defects (see boxed contraindications and warnings ). a single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients.1,3,4 if a second course of therapy is needed, it should not be initiated until at least 8 weeks after completion of the first course, because experience has shown that patients may c